Clinical Trials Browser

Phase 3 × Recruiting × penpulimab × Clear all

NCT05862337 2023-05-17

Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular